These immunohistochemistry staining results are also consistent with the E-cad protein expression profiles revealed by the mass spectrometry analysis, which demonstrated that E-cad expression was upregulated or remained unchanged in most carcinoma tissues (Fig. 4A-B) and was expressed at higher levels in most of the carcinoma cell lines analyzed (Table 3). The gene discussed is CDH1; the disease is carcinoma.